Ranasinghe, Ranmali
< Back to all AuthorsArticle
Article
Ranasinghe, Ranmali ORCID: 0000-0003-3634-2689, Mathai, Michael ORCID: 0000-0001-8783-2122, Abdullah Alshawsh, Mohammed and Zulli, Anthony ORCID: 0000-0002-2660-078X (2024) Nanocarrier-mediated cancer therapy with cisplatin: A meta-analysis with a promising new paradigm. Heliyon, 10 (7). ISSN 2405-8440
Ranasinghe, Ranmali ORCID: 0000-0003-3634-2689, Mathai, Michael ORCID: 0000-0001-8783-2122 and Zulli, Anthony ORCID: 0000-0002-2660-078X (2023) Cytoprotective remedies for ameliorating nephrotoxicity induced by renal oxidative stress. Life Sciences, 318. ISSN 0024-3205
Ranasinghe, Ranmali ORCID: 0000-0003-3634-2689, Mathai, Michael ORCID: 0000-0001-8783-2122 and Zulli, Anthony ORCID: 0000-0002-2660-078X (2022) Cisplatin for cancer therapy and overcoming chemoresistance. Heliyon, 8 (9). ISSN 2405-8440
Ranasinghe, Ranmali ORCID: 0000-0003-3634-2689, Mathai, Michael ORCID: 0000-0001-8783-2122 and Zulli, Anthony ORCID: 0000-0002-2660-078X (2022) Revisiting the therapeutic potential of tocotrienol. BioFactors. ISSN 0951-6433
Ranasinghe, Ranmali ORCID: 0000-0003-3634-2689, Mathai, Michael ORCID: 0000-0001-8783-2122 and Zulli, Anthony ORCID: 0000-0002-2660-078X (2022) A synopsis of modern - day colorectal cancer: where we stand. Biochimica et Biophysica Acta - Reviews on Cancer, 1877 (2). ISSN 0304-419X